Neonatal side effects of maternal labetalol treatment in severe preeclampsia

Early Human Development

Volumn 88, Issue 7, 2012, Pages 503-507

  Heida, Karst Y ^a   Zeeman, Gerda G ^a   Van Veen, Teelkien R ^a   Hulzebos, Christian V ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bradycardia; Hypoglycemia; Hypotension; Labetalol; Patent ductus arteriosus (PDA)

Indexed keywords

DOPAMINE; GLUCOSE; HYDROCORTISONE; LABETALOL;

ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; CONTINUOUS INFUSION; CONTROLLED STUDY; CRYSTALLOID; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANT; INTUBATION; MAJOR CLINICAL STUDY; MALE; NEWBORN ASSESSMENT; NEWBORN DISEASE; NEWBORN MONITORING; PATENT DUCTUS ARTERIOSUS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; RISK ASSESSMENT;

ADULT; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; FEMALE; FETAL DEATH; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; LABETALOL; MALE; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84861680516     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.12.012     Document Type: Article

References (31)

1. Chesley's hypertensive disorders in pregnancy 2009, Elsevier Inc., San Diego. 3rd ed. M.D. Lindheimer, J.M. Roberts, F.G. Cunningham (Eds.).
2. Langenveld J., Ravelli A.C., Van Kaam A.H., van der Ham D.P., van Pampus M.G., Portath M., et al. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37weeks of gestation: a 7year retrospective analysis of a national registry. Am J Obstet Gynecol Dec 2011, 205(6). 540.e1-7.
3. Vigil-De Gracia P., Lasso M., Ruiz E., Vega-Malek J.C., de Mena F.T., Lopez J.C. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol Sep 2006, 128(1-2):157-162.
4. Sibai B.M. Treatment of hypertension in pregnant women. N Engl J Med Jul 25 1996, 335(4):257-265.
5. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol Jul 2000, 183(1):S1-S22.
6. Duley L., Henderson-Smart D.J., Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006, 3:CD001449.
7. Michael C.A. The evaluation of labetalol in the treatment of hypertension complicating pregnancy. Br J Clin Pharmacol Jun 1982, 13(1 Suppl.):127S-131S.
8. Macpherson M., Broughton Pipkin F., Rutter N. The effect of maternal labetalol on the newborn infant. Br J Obstet Gynaecol Jun 1986, 93(6):539-542.
9. Brosset P., Ronayette D., Delhoume B., Lacapeyre F., Alain J., Collet D., et al. Metabolic and cardiovascular effects of beta-blockers taken by the mother in newborn infants. Presse Med Mar 19 1988, 17(10):467-470.
10. Haraldsson A., Geven W. Severe adverse effects of maternal labetalol in a preterm infant. Acta Paediatr Scand Nov 1989, 78(6):956-958.
11. Klarr J.M., Bhatt-Mehta V., Donn S.M. Neonatal adrenergic blockade following single dose maternal labetalol administration. Am J Perinatol Mar 1994, 11(2):91-93.
12. Sala X., Monsalve C., Comas C., Botet F., Nalda M.A. Cardiac arrest in newborn of mother treated with labetalol. Rev Esp Anestesiol Reanim May 1993, 40(3):146-147.
13. Stevens T.P., Guillet R. Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy. J Pediatr Jul 1995, 127(1):151-153.
14. Olsen K.S., Beier-Holgersen R. Fetal death following labetalol administration in pre-eclampsia. Acta Obstet Gynecol Scand Feb 1992, 71(2):145-147.
15. Efird M.M., Heerens A.T., Gordon P.V., Bose C.L., Young D.A. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol Feb 2005, 25(2):119-124.
16. Holtrop P.C. The frequency of hypoglycemia in full-term large and small for gestational age newborns. Am J Perinatol Mar 1993, 10(2):150-154.
17. Woods D.L., Malan A.F. Side effects of labetalol in newborn infants. Br J Obstet Gynaecol Sep 1983, 90(9):876.
18. Jouppila P., Rasanen J. Effect of labetalol infusion on uterine and fetal hemodynamics and fetal cardiac function. Eur J Obstet Gynecol Reprod Biol Oct 1993, 51(2):111-117.
19. Cissoko H., Jonville-Bera A.P., Swortfiguer D., Giraudeau B., Autret-Leca E. Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy. Arch Pediatr May 2005, 12(5):543-547.
20. The Netherlands Perinatal Registry http://www.perinatreg.nl.
21. Al Aweel I., Pursley D.M., Rubin L.P., Shah B., Weisberger S., Richardson D.K. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol Jul 2001, 21(5):272-278.
22. Dasgupta S.J., Gill A.B. Hypotension in the very low birthweight infant: the old, the new, and the uncertain. Arch Dis Child Fetal Neonatal Ed Nov 2003, 88(6):F450-F454.
23. Spinazzola R.M., Harper R.G., de Soler M., Lesser M. Blood pressure values in 500- to 750-gram birthweight infants in the first week of life. J Perinatol Jun 1991, 11(2):147-151.
24. Launer L.J., Hofman A., Grobbee D.E. Relation between birth weight and blood pressure: longitudinal study of infants and children. BMJ Dec 4 1993, 307(6917):1451-1454.
25. Alves J.G., Vilarim J.N., Figueiroa J.N. Fetal influences on neonatal blood pressure. J Perinatol Dec 1999, 19(8 Pt 1):593-595.
26. Ellison R.C., Peckham G.J., Lang P., Talner N.S., Lerer T.J., Lin L., et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics Mar 1983, 71(3):364-372.
27. MacCarthy E.P., Bloomfield S.S. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy Jul 1983, 3(4):193-219.
28. Rogers R.C., Sibai B.M., Whybrew W.D. Labetalol pharmacokinetics in pregnancy-induced hypertension. Am J Obstet Gynecol Feb 1990, 162(2):362-366.
29. Crooks B.N., Deshpande S.A., Hall C., Platt M.P., Milligan D.W. Adverse neonatal effects of maternal labetalol treatment. Arch Dis Child Fetal Neonatal Ed Sep 1998, 79(2):F150-F151.
30. Munshi U.K., Deorari A.K., Paul V.K., Singh M. Effects of maternal labetalol on the newborn infant. Indian Pediatr Dec 1992, 29(12):1507-1512.
31. Pickles C.J., Symonds E.M., Broughton Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol Jan 1989, 96(1):38-43.